Skip to main content
Fig. 3 | BMC Musculoskeletal Disorders

Fig. 3

From: Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis

Fig. 3

Forest plot for comparing the total DVT rate between (a) LMWH vs. control (placebo), (b) LMWH vs. inhibitor of factor Xa, and (c) LMWH vs. direct thrombin inhibitor for THR and TKR patients. Abbreviations: CI, confidence interval; Lower limit, lower bound of the 95% CI; Upper limit, upper bound of the 95% CI

Back to article page